Hepatoprotective and cardioprotective effects of empagliflozin in spontaneously hypertensive rats fed a high-fat diet-Reference-Cited by-同舟云学术

Hepatoprotective and cardioprotective effects of empagliflozin in spontaneously hypertensive rats fed a high-fat diet

Published:2024-05 Issue: Volume:174 Page:116520
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Hojná Silvie,Malínská Hana,Hüttl Martina,Vaňourková Zdeňka,Marková Irena^ORCID,Miklánková Denisa,Hrdlička Jaroslav,Papoušek František,Neckář Jan,Kujal Petr,Behuliak Michal,Rauchová Hana,Kadlecová Michaela,Sedmera David,Neffeová Kristýna,Zábrodská Eva^ORCID,Olejníčková Veronika,Zicha Josef,Vaněčková Ivana

Publisher

Elsevier BV

Reference67 articles.

1. Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease;Lim;Trends Endocrinol. Metab.,2021

2. Sex differences in hypertension: lessons from spontaneously hypertensive rats (SHR);Elmarakby;Clin. Sci. (Lond. ),2021

3. Combination of hypertension along with a high fat and cholesterol diet induces severe hepatic inflammation in rats via a signaling network comprising NF-κB, MAPK, and Nrf2 pathways;Yuan;Nutrients,2017

4. Dietary-induced obesity hastens the progression from concentric cardiac hypertrophy to pump dysfunction in spontaneously hypertensive rats;Majane;Hypertension,2009

5. The sodium-glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure rats;Lee;Cardiovasc. Diabetol.,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gliflozins in the Treatment of Non-diabetic Experimental Cardiovascular Diseases;Physiological Research;2024-08-31